Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Amyloid Fibrils03:03

Amyloid Fibrils

9.9K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An astrocytic ensemble at vHip-NAc synapses modulates cognitive impairments induced by chronic tetrahydrocannabinol exposure.

Nature communications·2025
Same author

Increasing Temperature Activates TREK Potassium Currents in Vagal Afferent Neurons from the Nodose Ganglion.

International journal of molecular sciences·2025
Same author

Voltage-gated potassium channel isoform upregulation and functional alterations in multiple sclerosis peripheral blood mononuclear cells.

International immunopharmacology·2025
Same author

Astroglial CB<sub>1</sub> Reveal Sex-Specific Synaptic Effects of Amphetamine.

Glia·2025
Same author

Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia.

Schizophrenia research·2024
Same author

Cannabinoids regulate an insula circuit controlling water intake.

Current biology : CB·2024
Same journal

Correction: Acetylcholine receptor stimulation activates protein kinase C mediated internalization of the dopamine transporter.

Frontiers in cellular neuroscience·2026
Same journal

Defining spinal motor neuron subtypes across development: from embryonic specification to postnatal maturation.

Frontiers in cellular neuroscience·2026
Same journal

Brief mechanical pulses induce sustained intracellular L-lactate production in astrocytes.

Frontiers in cellular neuroscience·2026
Same journal

Effects of ethanol leaf extract of <i>Spondias mombin</i> on scopolamine-induced hippocampal neurodegeneration in adult male Wistar rats: evidence from behavioral, biochemical, histological, and immunohistochemical analyses.

Frontiers in cellular neuroscience·2026
Same journal

Ferroptosis in intracerebral hemorrhage: a bibliometric overview of mechanisms and future directions.

Frontiers in cellular neuroscience·2026
Same journal

<i>Scn2a</i>, encoding Na <sub><i>V</i></sub> 1.2 channel, contributes to tonotopic maturation of spike kinetics in developing mouse MNTB.

Frontiers in cellular neuroscience·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Studying Pre-formed Fibril Induced &#945;-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K

Astrocyte alterations in α-synucleinopathies.

Manuela Rodríguez-Castañeda1,2,3, Ana Campos-Ríos1,3, Jose Antonio Lamas1,3

  • 1Department of Functional Biology and Health Sciences, University of Vigo, Vigo, Spain.

Frontiers in Cellular Neuroscience
|August 22, 2025
PubMed
Summary
This summary is machine-generated.

Astrocytes, once thought passive, are now known key regulators. This study explores how astrocytes express alpha-synuclein (α-synuclein) and its role in neurodegenerative diseases like Parkinson's, impacting cellular function and disease progression.

Keywords:
astrocytesgliotransmissiontripartite synapseα-synucleinα-synucleinopathies

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.5K
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
06:43

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

12.3K

Related Experiment Videos

Last Updated: Sep 10, 2025

Studying Pre-formed Fibril Induced &#945;-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.5K
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
06:43

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

12.3K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Neurodegeneration

Background:

  • Astrocytes are increasingly recognized as active participants in brain function, moving beyond their traditional supportive role.
  • The tripartite synapse model highlights the crucial interactions between astrocytes and neurons.
  • Emerging evidence implicates astrocytes in the pathogenesis of neurodegenerative disorders, particularly α-synucleinopathies.

Purpose of the Study:

  • To discuss the expression of endogenous α-synuclein in astrocytes.
  • To explore the implications of α-synuclein in astrocyte cellular processes.
  • To review the impact of pathological α-synuclein in astrocytes on calcium signaling, gliotransmission, and disease progression.

Main Methods:

  • Literature review of recent evidence on astrocyte function and α-synuclein.
  • Analysis of studies investigating astrocyte-specific α-synuclein expression.
  • Examination of research on the consequences of aberrant α-synuclein in astrocytes.

Main Results:

  • Astrocytes express endogenous α-synuclein, influencing their cellular functions.
  • Pathological forms of α-synuclein in astrocytes lead to disrupted cytosolic calcium (Ca2+) activity.
  • Altered gliotransmission and accelerated pathology progression are observed due to astrocyte-expressed α-synuclein.

Conclusions:

  • Astrocytes play a significant role in the pathophysiology of α-synucleinopathies.
  • Astrocyte-specific α-synuclein dysfunction contributes to neurodegenerative processes.
  • Targeting astrocyte α-synuclein may offer therapeutic strategies for neurodegenerative diseases.